Victor Mor-Avi Selected Research

regadenoson

9/2019	Hemodynamic impact of coronary stenosis using computed tomography: comparison between noninvasive fractional flow reserve and 3D fusion of coronary angiography with stress myocardial perfusion.
1/2018	Fusion of Three-Dimensional Echocardiographic Regional Myocardial Strain with Cardiac Computed Tomography for Noninvasive Evaluation of the Hemodynamic Impact of Coronary Stenosis in Patients with Chest Pain.
6/2017	Non-invasive assessment of the haemodynamic significance of coronary stenosis using fusion of cardiac computed tomography and 3D echocardiography.
12/2013	Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
12/2012	Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
7/2012	Quantitative three-dimensional evaluation of myocardial perfusion during regadenoson stress using multidetector computed tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Mor-Avi Research Topics

Disease

6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2009
5	Heart Failure 02/2020 - 07/2009
4	Myocardial Infarction 01/2020 - 12/2013
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2008
3	Pathologic Constriction (Stenosis) 09/2019 - 07/2011
3	Chest Pain (Chest Pains) 09/2019 - 06/2017
2	Cicatrix (Scar) 01/2019 - 04/2016
2	Aortic Valve Stenosis (Aortic Stenosis) 05/2017 - 11/2010
2	Sarcoidosis (Schaumann Disease) 05/2016 - 01/2016
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 05/2016 - 04/2014
2	Hyperemia 12/2013 - 12/2012
1	Amyloidosis 01/2022
1	Syncope (Fainting) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 03/2020
1	Coronary Disease (Coronary Heart Disease) 03/2020
1	Infarction (Infarctions) 04/2016
1	Ischemia 04/2016
1	Atherosclerosis 03/2016
1	Ventricular Tachycardia 01/2016
1	Pulmonary Arterial Hypertension 01/2014
1	Pulmonary Hypertension 02/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2011
1	Coronary Occlusion 01/2006

Drug/Important Bio-Agent (IBA)

7	Vasodilator Agents (Vasodilators)IBA 01/2022 - 05/2008
7	GadoliniumIBA 01/2020 - 02/2012
6	regadenoson FDA Link 09/2019 - 07/2012
2	Aminophylline (Carine)FDA LinkGeneric 12/2013 - 12/2012
2	Dobutamine FDA LinkGeneric 11/2011 - 05/2009
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cytidine Triphosphate (CTP)IBA 03/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2020
1	A 7 (A-7)IBA 05/2016
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 05/2016
1	oxidized low density lipoproteinIBA 03/2016
1	LipidsIBA 03/2016
1	Pharmaceutical PreparationsIBA 01/2014
1	omega-Chloroacetophenone (Mace)IBA 12/2013
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2012
1	Phenobarbital (Luminal)FDA Link 07/2011

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2014
2	Transcatheter Aortic Valve Replacement 05/2017 - 11/2010
2	Cardiac Resynchronization Therapy 04/2014 - 07/2009
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019
1	Transplantation 01/2016
1	Defibrillators (Defibrillator) 04/2014
1	Lung Transplantation 02/2012
1	Microspheres (Microsphere) 01/2006